Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate for erosive tophaceous gout
ACTRN12608000463370Phase 3Completed
- Sponsor
- The University of Auckland
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of zoledronate in gout, sponsored by The University of Auckland. Started Dec 2008; status: completed.
02
Drugs
zoledronate
03
Conditions
gout
Beyond the preview
Go deeper on ACTRN12608000463370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000463370.